METHOD OF PERIPHERAL NERVE DAMAGE TREATMENT Russian patent published in 2008 - IPC A61N1/32 A61K31/51 A61K31/165 A61K38/47 A61P25/02 

FIELD: medicine.

SUBSTANCE: neurolysis, autoneuroplasty of nerve defect are carried out from 2-3th day after direct electrostimulation operation of proximal end of injured nerve, zones of neuroraffia and autoneurotransplant by electroneuromyography (ENMG) results. Additionally, medical products vitamins B₁ and/or B₁₂, and/or C, and/or Berliotin and spasmolytics are introduced. ENMG is applied for area above plastics zone and if in 2-3 weeks there is no evoked potential response, neuroma is excised or reautoneurotransplantation is applied. Following direct electrostimulation is accompanied with introduction of medical products: growth-promoting agents and spasmolytics; electrophoresis with iodine and/or lidase. If after that in 3-4 weeks evoked potentials are recorded to be frequency and amplitude, in addition transcutaneous electrostimulation of enervated muscles combined with introduction of lidase, anticholinesterase agents and spasmolytics. After implanted electrodes are removed, transcutaneous electrostimulation is applied from proximal end of nerve to innervated muscle zones within 5-7 days. If evoked response is not recorded, cicatrical adhesive tissue is excised in area of enervated muscles and/or neurotransplant bed combined with introduction of lidase. Direct electrostimulation of plastics zone and enervated muscles is repeated till evoked response is recorded, then transcutaneous electrostimulation of restored muscles is applied combined with introduction of anticholinesterase agents within 4-6 weeks. However if 1-2 weeks after muscular response to stimulation is not recorded, automyoplastics is applied.

EFFECT: method provides higher efficiency of treatment.

13 cl, 1 ex